CardioPharma Reviews Applications to Explore Non-Cardiovascular Benefits of CVD Polypill

B WILMINGTON, N.C., May 12, 2026 /PRNewswire/ — CardioPharma, Inc., a specialty pharmaceutical company focused on combinatorial drug development for cardiovascular disease, is currently reviewing…
posteditor
posteditor
Articles: 17424

Other News